Keywords
COVID-19, coronavirus, cytokine storm syndrome, computed tomography, corticosteroids
Abstract
Background: In June 2020, a large randomised controlled clinical trial in the UK found that dexamethasone was effective in reducing the number of deaths in patients with severe coronavirus disease 2019 (COVID-19).
Case description: We describe a patient with rapid worsening of COVID-19 pneumonia and its dramatic improvement under corticosteroids.
Discussion: Corticosteroids could be useful in patients with an inflammatory profile, considering that acute respiratory distress syndrome may be the consequence of cytokine storm syndrome.
References
![](https://www.ejcrim.com/public/journals/1/article_1822_cover_en_US.jpg)
Views: 673
HTML downloads: 285
PDF downloads: 381
Published:
2020-07-02
Issue:
2020: Vol 7 No 7
(view)